Canagliflozin antidiabetic drugs  

Invokana      

Select             pdf
Trial Studied trt Control trt patientstagsROB Trial resultcardiovascular eventsCardiovascular death

diabetes type 2  

CANVAS, 2017            NCTcanagliflozinplaceboLow risk of bias conclusive -14%-13%